The embodiments provide compounds of the general Formulae I through general Formula
VIII, as well as compositions, including pharmaceutical compositions, comprising a subject …

US8119592B2 - Compounds and methods for inhibiting hepatitis C viral replication - Google
Patents US8119592B2 - Compounds and methods for inhibiting hepatitis C viral replication …

5,034,394 A 7/1991 Daluge 5,149,820 A 9/1992 Borretzen et al. 5,232,928 A 8/1993 Skiles
5,624,949 A 4/1997 Heath et a1. 5,656,627 A 8/1997 Bemis et a1. 5,756,466 A 5/1998 …

US8648037B2 - Macrocyclic proline derived HCV serine protease inhibitors - Google
Patents US8648037B2 - Macrocyclic proline derived HCV serine protease inhibitors …

2015-03-19 Assigned to ISTITUTO DI RICERCHE DI BIOLOGIA MOLECULARE P
ANGELLETTI SRL reassignment ISTITUTO DI RICERCHE DI BIOLOGIA MOLECULARE P …

The embodiments provide compounds of the general Formulae I, II, III, IV, V, VI, VII, and X, as
well as compositions, including pharmaceutical compositions, comprising a subject …

WO2017197036A1 - Spirocyclic degronimers for target protein degradation - Google Patents
WO2017197036A1 - Spirocyclic degronimers for target protein degradation - Google Patents …

The embodiments provide compounds of the general For mula I, as well as compositions,
including pharmaceutical compositions, comprising a subject compound. The embodi ments …

The present invention relates to novel macrocyclic com pounds and methods of treating a
hepatitis C infection in a Subject in need of Such therapy with said macrocyclic com pounds …

The embodiments provide compounds of the general Formulae (I) through general Formula
(VIII), as well as compositions, including pharmaceutical compositions, comprising a subject …